This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked MSI2 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-MSI2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~35.2 kDa | |
| Observed band | ~35 kDa | |
| Gel | 10% (catalog A02898-2) | |
| Positive control | Adrenal gland (IHC candidate; verify WB) +4 more | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Phosphorylated + Acetylated | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 3 isoform(s) |
The A02898-2 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | human SH-SY5Y, human RT4, human U251, human HepG2, rat brain, rat C6, mouse brain, mouse Neuro-2a (catalog A02898-2) |
| Gel % | 10% (catalog A02898-2) |
| Load | 30 ug; reducing conditions (catalog A02898-2) |
| Transfer | a nitrocellulose membrane at 150 mA for 50-90 minutes (catalog A02898-2) |
| Membrane | nitrocellulose membrane (catalog A02898-2) |
| Blocking | 5% non-fat milk/TBS for 1.5 hour at RT (catalog A02898-2) |
| Primary antibody | A02898-2 · 0.5 μg/mL (catalog A02898-2) |
| Primary incubation | overnight at 4°C (catalog A02898-2) |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 (catalog A02898-2) |
| Secondary incubation | 1.5 hour at RT (catalog A02898-2) |
| Wash | TBS-0.1%Tween 3 times with 5 minutes each (catalog A02898-2) |
| Detection | ECL (catalog A02898-2) |
MSI2 is predicted at 35.2 kDa and observed at ~35 kDa; the small difference has no established cause, and band identity needs controls.
| Band at ~35 kDa | Matches the empirical MSI2 band and its 35.2 kDa predicted mass; confirm identity with controls |
| Additional bands at different positions | Could reflect isoforms 1, 2, or 3; their migration is not established |
| Close doublet near 35 kDa | Could reflect phosphorylation, but a visible shift has not been demonstrated |
| Faint ~35 kDa band in whole-cell lysate | Cytoplasmic MSI2 may be poorly detected in this preparation |
| Predicted MSI2 mass | 35.2 kDa predicts migration near the empirical ~35 kDa band |
| Isoforms 1, 2, and 3 | May differ in size, but their masses and resolvable migration are not supplied |
| Phosphoserine at position 6 and annotated position 261 | May alter mobility; no visible shift is established |
| N-acetylmethionine at position 1 | Adds a small modification without an established visible shift |
| Omega-N-methylarginine at position 228 and annotated position 261 | Adds small modifications without an established visible shift |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Cytoplasmic MSI2 may be poorly recovered or detected | Check cytoplasmic extraction and run a positive-control lysate |
| Band higher than expected | A different isoform or modified MSI2 is possible; the cause is unproven | Compare with a positive control and verify identity by MSI2 depletion |
| Band lower than expected | An alternative isoform or degradation is possible; neither migration is established | Use MSI2 depletion and check sample handling |
| Multiple bands | Isoforms 1, 2, and 3 or modified MSI2 may contribute | Check band identity by MSI2 depletion; compare isoform-specific expression if available |
| Weak or no signal | MSI2 detection in this preparation may be low | Verify loading, transfer, and signal with a positive-control lysate |
| Fragments below expected size | MSI2 degradation is possible given its reported ubiquitination and degradation | Prepare fresh lysate with protease inhibitors and verify fragments by MSI2 depletion |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adrenal gland | glandular cells | High | Protein (IHC) | HPA → |
| Appendix | glandular cells | High | Protein (IHC) | HPA → |
| Breast | glandular cells | High | Protein (IHC) | HPA → |
| Caudate | neuronal cells | High | Protein (IHC) | HPA → |
| Cerebral cortex | glial cells | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Lymph node | non-germinal center cells | Low | Protein (IHC) | HPA → |
| Adipose tissue | adipocytes | Medium | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | Medium | Protein (IHC) | HPA → |
| Bronchus | respiratory epithelial cells | Medium | Protein (IHC) | HPA → |
| Cerebellum | cells in granular layer | Medium | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for MSI2, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
Three the supplier anti-MSI2 antibodies list human, mouse, and rat reactivity and have WB images. A02898-2 reports a band near 35 kDa across named human, rat, and mouse lysates; the other two captions describe single lysates without comparable conditions.
Which to pick: Choose A02898-2 for the most detailed WB example, including sample types and conditions. M02898 shows T47 D cell lysate, while A02898 shows EL4 cell lysate at 1 μg/mL. All three list the same species reactivity.